Cookie Consent by PrivacyPolicies.com

Frequently Asked Questions

Chroniberia is a prognostic index for chronic patients developed by the Multiple Pathology and Advanced Age Unit of the Complexo Hospitalario Universitario de Santiago de Compostela (Spain).
Chroniberia can be used as a prognostic value for mortality at one year in both chronic and multipathological patients.

The Chroniberia index is calculated from only five variables: age, sex, neoplasia, Barthel index, and presence of atrial fibrillation.

Neoplasia: active solid or hematological neoplasia not subsidiary to treatment with curative intent Ministry of Health and Social Policy. Patients polypathological unit. Standards and recommendations. Madrid. 2009 Available from http://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/docs/EyR_UPP.pdf .

Atrial fibrillation: includes paroxysmal, persistent or permanent AF with CHA2DS2-VASc ≥2 in men and ≥ 3 in women (evidence class I A). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal (2020) 42, 373-498 doi:10.1093/eurheartj/ehaa612

Chroniberia works like a calculator. After setting the appropriate values ​​for the five variables using the controls on the form, the prognostic value will be calculated automatically. The application also includes the Barthel test. You can find a link to the Barthel test on the main page of the application, next to the corresponding fields. Fill in the new form and press the “Accept” button to update the Chroniberia main form with the corresponding test result.